93 related articles for article (PubMed ID: 1597732)
41. Decreased hepatic function in patients with hepatoma or liver metastasis monitored by a hepatocyte specific galactosylated radioligand.
Virgolini I; Müller C; Klepetko W; Angelberger P; Bergmann H; O'Grady J; Sinzinger H
Br J Cancer; 1990 Jun; 61(6):937-41. PubMed ID: 2164838
[TBL] [Abstract][Full Text] [Related]
42. Hepatic uptake of [99mTc]galactosyl-neoglycoalbumin is sensitive to receptor quantity.
Kudo M; Vera DR; Trudeau WL; Stadalnik RC
Int J Rad Appl Instrum B; 1991; 18(7):663-6. PubMed ID: 1787074
[TBL] [Abstract][Full Text] [Related]
43. Maleimidoethyl 3-(tri-n-butylstannyl)hippurate: a useful radioiodination reagent for protein radiopharmaceuticals to enhance target selective radioactivity localization.
Arano Y; Wakisaka K; Ohmomo Y; Uezono T; Mukai T; Motonari H; Shiono H; Sakahara H; Konishi J; Tanaka C
J Med Chem; 1994 Aug; 37(16):2609-18. PubMed ID: 8057303
[TBL] [Abstract][Full Text] [Related]
44. 67Ga-labeled antibodies for immunoscintigraphy and evaluation of tumor targeting of drug-antibody conjugates in mice.
Koizumi M; Endo K; Kunimatsu M; Sakahara H; Nakashima T; Kawamura Y; Watanabe Y; Saga T; Konishi J; Yamamuro T
Cancer Res; 1988 Mar; 48(5):1189-94. PubMed ID: 3422590
[TBL] [Abstract][Full Text] [Related]
45. [Pharmacokinetic studies on 99mTc-NGA in human].
Guan C; Chen Q; Tan T
Hua Xi Yi Ke Da Xue Xue Bao; 1993 Sep; 24(3):268-70. PubMed ID: 8288194
[TBL] [Abstract][Full Text] [Related]
46. In-vivo evaluation of indium-111-diethylenetriaminepentaacetic acid-labelling for determining the sites and rates of protein catabolism in mice.
Mukai T; Arano Y; Nishida K; Sasaki H; Saji H; Nakamura J
J Pharm Pharmacol; 1999 Jan; 51(1):15-20. PubMed ID: 10197412
[TBL] [Abstract][Full Text] [Related]
47. Preparation of 67Ga-labeled antibodies using deferoxamine as a bifunctional chelate. An improved method.
Koizumi M; Endo K; Kunimatsu M; Sakahara H; Nakashima T; Kawamura Y; Watanabe Y; Ohmomo Y; Arano Y; Yokoyama A
J Immunol Methods; 1987 Nov; 104(1-2):93-102. PubMed ID: 3316401
[TBL] [Abstract][Full Text] [Related]
48. Tc-99m galactosyl-neoglycoalbumin hepatic scintigraphy in fulminant hepatic failure.
Moragas M; Pavía J; Ginés A; Ros D; Solá M; Huguet M; Pons F; Setoain J
Clin Nucl Med; 1995 Apr; 20(4):329-33. PubMed ID: 7788990
[TBL] [Abstract][Full Text] [Related]
49. Tc-NGA imaging in liver transplantation: preliminary clinical experience.
Woodle ES; Ward RE; Stadalnik RC; Vera DR
Surgery; 1989 Mar; 105(3):401-7. PubMed ID: 2646744
[TBL] [Abstract][Full Text] [Related]
50. Comparisons of labeling efficiency, biological activity and biodistribution among 125I-, 67Ga-DTPA-and 67Ga-DFO-lectins.
Kojima S; Jay M
Eur J Nucl Med; 1987; 13(7):366-70. PubMed ID: 3428286
[TBL] [Abstract][Full Text] [Related]
51. [Characterization of receptor-mediated binding of 99mTc-NGA in vitro].
Guan C; Chen Q; Tan T
Hua Xi Yi Ke Da Xue Xue Bao; 1994 Mar; 25(1):22-5. PubMed ID: 8070765
[TBL] [Abstract][Full Text] [Related]
52. Radiopharmaceutical preparation of technetium-99m-labeled galactosyl neoglycoalbumin.
Vera DR; Stadalnik RC; Kudo M; Krohn KA
Methods Enzymol; 1994; 247():402-9. PubMed ID: 7898368
[No Abstract] [Full Text] [Related]
53. Species difference in radioactivity elimination from liver parenchymal cells after injection of radiolabeled proteins.
Mukai T; Arano Y; Nishida K; Sasaki H; Akizawa H; Ogawa K; Ono M; Saji H; Nakamura J
Nucl Med Biol; 1999 Apr; 26(3):281-9. PubMed ID: 10363799
[TBL] [Abstract][Full Text] [Related]
54. N-Succinyldesferrioxamine B: a potential radiopharmaceutical for assessing renal function.
Herscheid JD; Hoekstra A; Vos CM
Eur J Nucl Med; 1984; 9(11):508-10. PubMed ID: 6549165
[TBL] [Abstract][Full Text] [Related]
55. Basic evaluation of 67Ga labeled digoxin derivative as a metal-labeled bifunctional radiopharmaceutical.
Fujibayashi Y; Takemura Y; Taniuchi H; Iijima N; Konishi J; Yokoyama A
Ann Nucl Med; 1993 Nov; 7(4):239-44. PubMed ID: 8292449
[TBL] [Abstract][Full Text] [Related]
56. Measurement of functioning hepatocyte mass via [99mTc]galactosyl-neoglycoalbumin.
Kudo M; Vera DR; Stadalnik RC; Esquivel CO; Trudeau WL; Ikekubo K; Todo A
Dig Dis Sci; 1993 Dec; 38(12):2183-8. PubMed ID: 8261818
[TBL] [Abstract][Full Text] [Related]
57. The use of electroimmunoassay for the determination of the in vivo stability of labelled proteins.
Jánoki GA; Körösi L
Nucl Med Commun; 1988 May; 9(5):339-45. PubMed ID: 3412726
[TBL] [Abstract][Full Text] [Related]
58. Desferoxamine mesylate (Desferal): a contrast-enhancing agent for gallium-37 imaging.
Hoffer PB; Samuel A; Bushberg JT; Thakur M
Radiology; 1979 Jun; 131(3):775-9. PubMed ID: 441388
[TBL] [Abstract][Full Text] [Related]
59. Development of Ga-67 labeled DFO-DAS-fibrinogen conjugate as a thrombus imaging agent.
Yamaoka S
Radiat Med; 1987; 5(5):151-3. PubMed ID: 3438481
[TBL] [Abstract][Full Text] [Related]
60. Cy5.5-DTPA-galactosyl-dextran: a fluorescent probe for in vivo measurement of receptor biochemistry.
Vera DR; Hall DJ; Hoh CK; Gallant P; McIntosh LM; Mattrey RF
Nucl Med Biol; 2005 Oct; 32(7):687-93. PubMed ID: 16243643
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
